Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure

被引:60
作者
Jankowska, Ewa A.
Ponikowska, Beata
Majda, Jacek
Zymlinski, Robert
Trzaska, Mieczyslaw
Reczuch, Krzysztof
Borodulin-Nadzieja, Ludmila
Banasiak, Waldemar
Ponikowski, Piotr
机构
[1] Mil Hosp, Dept Cardiol, PL-50981 Wroclaw, Poland
[2] Wroclaw Med Univ, Dept Physiol, Wroclaw, Poland
[3] Mil Hosp, Dept Clin Biochem, PL-50981 Wroclaw, Poland
关键词
chronic heart failure; uric acid; prognosis; SERUM URIC-ACID; XANTHINE-OXIDASE; MOLECULAR-MECHANISMS; BLOOD-FLOW; DYSFUNCTION; ALLOPURINOL; DISEASE; MARKER;
D O I
10.1016/j.ijcard.2005.10.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In severe chronic heart failure (CHF) elevated serum levels of uric acid (UA) predict poor survival. This study investigates whether hyperuricaemia (defined as serum UA level >= 6.5 mg/dL) extends its prognostic value on population with less advanced CHF. Methods: We studied 119 consecutive patients with stable, mild-moderate CHF (88 men, age: 64 +/- 11 years, NYHA class I/II/III: 9/65/45, LVEF: 32 +/- 8%). Results: Serum UA level (mean: 6.2 +/- 2.0 mg/dL, range: 2.0-16.2 mg/dL) increased in parallel to CHF severity expressed as NYHA class (4.9 +/- 1.1 vs. 5.7 +/- 1.5 vs. 7.2 +/- 2.4 mg/dL, NYHA I vs. II vs. III; NYHA I, II vs. III, p < 0.01), inversely correlated with peak oxygen consumption (r = 0.39, p < 0.01) and LVEF (r = -0.31, p < 0.01), but not with renal function (expressed as creatinine clearance calculated from Cockcroft-Gault formula; r = -0.14, p > 0.1), and predicted inflammatory status as evidenced by the correlation with C-reactive protein (r=0.31, p=0.003). Hyperuricaemia was detected in 48 (40%) patients. During follow-up (mean: 580 +/- 209 days, > 18 months in all survivors), 27 (23%) patients died. Hyperuricaemia was related to impaired survival in univariate (HR 2.8, 95%CI: 1.3-6.1, p=0.01) and multivariate analyses (adjusted for NYHA class and impaired renal function-the only mortality predictors in this population; p < 0.05). The 18-month survival for CHF patients with hyperuricaemia was 71% (95% CI: 58-84%) vs. 89% (95% CI: 81-96%) in those with normal UA level (p=0.01). Conclusion: In patients with mild-moderate CHF, hyperuricaemia predicts exercise intolerance and inflammatory activation and is strongly and independently related to poor prognosis. Whether elevated serum UA level may become a novel therapeutic target in CHF, deserves further studies. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 25 条
[1]   Metabolic, functional, and haemodynamic staging for CHF? [J].
Anker, SD ;
Coats, AJS .
LANCET, 1996, 348 (9041) :1530-1531
[2]   Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging [J].
Anker, SD ;
Doehner, W ;
Rauchhaus, M ;
Sharma, R ;
Francis, D ;
Knosalla, C ;
Davos, CH ;
Cicoira, M ;
Shamim, W ;
Kemp, M ;
Segal, R ;
Osterziel, KJ ;
Leyva, F ;
Hetzer, R ;
Ponikowski, P ;
Coats, AJS .
CIRCULATION, 2003, 107 (15) :1991-1997
[3]   Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure [J].
Anker, SD ;
Leyva, F ;
PooleWilson, PA ;
Kox, WJ ;
Stevenson, JC ;
Coats, AJS .
HEART, 1997, 78 (01) :39-43
[4]   THE APPLICATION OF A SENSITIVE URICASE-PEROXIDASE COUPLED REACTION TO A CENTRIFUGAL FAST ANALYZER FOR THE DETERMINATION OF URIC-ACID [J].
ARTISS, JD ;
ENTWISTLE, WM .
CLINICA CHIMICA ACTA, 1981, 116 (03) :301-309
[5]   Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications [J].
Berry, CE ;
Hare, JM .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 555 (03) :589-606
[6]   Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy [J].
Cappola, TP ;
Kass, DA ;
Nelson, GS ;
Berger, RD ;
Rosas, GO ;
Kobeissi, ZA ;
Marbán, E ;
Hare, JM .
CIRCULATION, 2001, 104 (20) :2407-2411
[7]   Uric acid in chronic heart failure [J].
Doehner, W ;
Anker, SD .
SEMINARS IN NEPHROLOGY, 2005, 25 (01) :61-66
[8]   Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies [J].
Doehner, W ;
Schoene, N ;
Rauchhaus, M ;
Leyva-Leon, F ;
Pavitt, DV ;
Reaveley, DA ;
Schuler, G ;
Coats, AJS ;
Anker, SD ;
Hambrecht, R .
CIRCULATION, 2002, 105 (22) :2619-2624
[9]   Uric acid in cachectic and noncachectic patients with chronic heart failure: Relationship to leg vascular resistance [J].
Doehner, W ;
Rauchhaus, M ;
Florea, VG ;
Sharma, R ;
Bolger, AP ;
Davos, CH ;
Coats, AJS ;
Anker, SD .
AMERICAN HEART JOURNAL, 2001, 141 (05) :792-799
[10]   The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction [J].
Dries, DL ;
Exner, DV ;
Domanski, MJ ;
Greenberg, B ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :681-689